Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNYSE:HUM
Previous Symbol
CUSIP44485910
Phone502-580-1000
Debt
Debt-to-Equity Ratio0.45
Current Ratio1.68
Quick Ratio1.68
Price-To-Earnings
Trailing P/E Ratio27.16
Forward P/E Ratio22.02
P/E Growth1.6
Sales & Book Value
Annual Sales$53.77 billion
Price / Sales0.81
Cash Flow$14.4419 per share
Price / Cash22.02
Book Value$77.22 per share
Price / Book4.12
Profitability
EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins2.70%
Return on Equity19.10%
Return on Assets6.36%
Miscellaneous
Employees45,900
Outstanding Shares137,190,000
Market Cap$46.32 billion
OptionableOptionable
Humana (NYSE:HUM) Frequently Asked Questions
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana announced a quarterly dividend on Friday, November 2nd. Stockholders of record on Monday, December 31st will be paid a dividend of $0.50 per share on Friday, January 25th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date is Friday, December 28th. View Humana's Dividend History.
How will Humana's stock buyback program work?
Humana declared that its board has authorized a share repurchase plan on Friday, December 15th 2017, which authorizes the company to buyback $3,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company's board of directors believes its stock is undervalued.
How were Humana's earnings last quarter?
Humana Inc (NYSE:HUM) issued its earnings results on Wednesday, November, 7th. The insurance provider reported $4.58 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $4.29 by $0.29. The insurance provider earned $14.21 billion during the quarter, compared to analysts' expectations of $13.97 billion. Humana had a return on equity of 19.10% and a net margin of 2.70%. During the same quarter last year, the company earned $3.39 EPS. View Humana's Earnings History.
When is Humana's next earnings date?
What guidance has Humana issued on next quarter's earnings?
Humana issued an update on its FY 2018 earnings guidance on Wednesday, November, 7th. The company provided earnings per share (EPS) guidance of $14.40-14.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.18. Humana also updated its FY18 guidance to ~$14.40 EPS.
What price target have analysts set for HUM?
19 Wall Street analysts have issued 1-year price targets for Humana's stock. Their forecasts range from $250.00 to $418.00. On average, they expect Humana's share price to reach $351.00 in the next twelve months. This suggests a possible upside of 10.4% from the stock's current price. View Analyst Price Targets for Humana.
What is the consensus analysts' recommendation for Humana?
19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 6 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.
What are Wall Street analysts saying about Humana stock?
Here are some recent quotes from research analysts about Humana stock:
- 1. According to Zacks Investment Research, "Shares of Humana have outperformed its industry’s growth year to date. Moreover, the company has witnessed its 2019 earnings estimates move upward over the last seven days. The insurer is well-poised for growth on its strong Medicare business. Its top line has been witnessing an uptrend for the past several years. Sufficient generation of cash flow has helped the company take up many capital deployment initiatives aimed at enhancing its shareholder value. Humana’s sound balance sheet and a disciplined capital management remain its major tailwinds. Acquisitions and dispositions made by the company have also led to business growth over the last few quarters. Following the solid second-quarter results and the buyouts of Curo Healthcare and Kindred, the company provided a bullish EPS guidance for 2018. However, its rising level of expenses persistently weighs on the bottom line." (10/5/2018)
- 2. Cantor Fitzgerald analysts commented, "This morning, Humana announced it would acquire a 40% interest in Curo Health Services, a large, privately-held hospice company." (4/23/2018)
Has Humana been receiving favorable news coverage?
Headlines about HUM stock have trended somewhat negative on Thursday, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Humana earned a news sentiment score of -1.4 on InfoTrie's scale. They also gave media coverage about the insurance provider a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an effect on the company's share price in the next few days.
Who are some of Humana's key competitors?
Who are Humana's key executives?
Humana's management team includes the folowing people:
- Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
- Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
- Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 55)
- Mr. Timothy S. Huval, Chief HR Officer (Age 52)
- Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)
Who are Humana's major shareholders?
Humana's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include FMR LLC (8.99%), BlackRock Inc. (8.94%), Capital International Investors (5.99%), Capital Research Global Investors (2.86%), Capital World Investors (2.45%) and Janus Henderson Group PLC (2.39%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.
Which major investors are selling Humana stock?
HUM stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, MERIAN GLOBAL INVESTORS UK Ltd, Wells Fargo & Company MN, Mitsubishi UFJ Trust & Banking Corp, Alliancebernstein L.P., AQR Capital Management LLC, Point72 Asset Management L.P. and Ceredex Value Advisors LLC. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.
Which major investors are buying Humana stock?
HUM stock was bought by a variety of institutional investors in the last quarter, including Capital International Investors, Renaissance Technologies LLC, Ffcm LLC, FMR LLC, BlackRock Inc., Deutsche Bank AG, Artemis Investment Management LLP and Cookson Peirce & Co. Inc.. View Insider Buying and Selling for Humana.
How do I buy shares of Humana?
Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Humana's stock price today?
One share of HUM stock can currently be purchased for approximately $318.01.
How big of a company is Humana?
Humana has a market capitalization of $46.32 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.
What is Humana's official website?
How can I contact Humana?
Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.
MarketBeat Community Rating for Humana (NYSE HUM)
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
